Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New therapies for asthma.

Peter J Barnes1

  • 1National Heart and Lung Institute, Imperial College, London, SW3 6LY, UK. p.j.barnes@imperial.ac.uk

Trends in Molecular Medicine
|October 3, 2006
PubMed
Summary
This summary is machine-generated.

Current asthma treatments are effective and inexpensive, posing a challenge for new therapies. Future asthma research may focus on severe asthma and potential vaccines targeting immune dysfunction.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mitochondrial dysfunction in lung ageing and disease.

European respiratory review : an official journal of the European Respiratory Society·2020
Same author

COPD 2020: new directions needed.

American journal of physiology. Lung cellular and molecular physiology·2020
Same author

Effect of a single day of increased as-needed budesonide-formoterol use on short-term risk of severe exacerbations in patients with mild asthma: a post-hoc analysis of the SYGMA 1 study.

The Lancet. Respiratory medicine·2020
Same author

Hepcidin Is Essential for Alveolar Macrophage Function and Is Disrupted by Smoke in a Murine Chronic Obstructive Pulmonary Disease Model.

Journal of immunology (Baltimore, Md. : 1950)·2020
Same author

Sex and gender: modifiers of health, disease, and medicine.

Lancet (London, England)·2020
Same author

Virus-Induced Asthma Exacerbations: SIRT1 Targeted Approach.

Journal of clinical medicine·2020

Area of Science:

  • Pulmonology and Immunology
  • Pharmacology

Background:

  • Asthma is a growing global health concern with persistent symptoms for many patients.
  • Existing inhaled corticosteroids and long-acting beta(2)-agonists offer effective, safe, and affordable asthma management.
  • The high efficacy of current treatments presents a significant barrier to developing superior therapies.

Purpose of the Study:

  • To address the unmet need for improved severe asthma treatments, which differ from mild/moderate asthma and resemble COPD.
  • To explore the potential for novel therapies targeting specific pathways, while acknowledging limitations.
  • To discuss the challenges and prospects for developing oral therapies for mild/moderate asthma and potential cures through immunotherapy.

Main Methods:

  • Review of current asthma treatment efficacy and limitations.

Related Experiment Videos

  • Analysis of emerging therapeutic strategies for severe asthma.
  • Evaluation of the feasibility of oral asthma medications and vaccine development.

    • Main Results:

    • Current combination inhaler therapy is highly effective and cost-efficient.
    • Severe asthma requires distinct treatment approaches, sharing similarities with COPD.
    • Many new targeted therapies may lack broad clinical impact; oral therapies face significant side effect concerns.

    Conclusions:

    • Developing significantly better treatments than current inhaled therapies is challenging.
    • Severe asthma represents a key area for therapeutic innovation.
    • Vaccine development targeting aberrant immune responses offers a potential long-term strategy for asthma management and cure.